XELJANZ identity
The active ingredient recorded for this profile is Tofacitinib. Confirm the prescribed brand or ingredient before comparing packages.
Specialty Care medication reference
XELJANZ price reference.
XELJANZ (Tofacitinib) has 14 European package references in this catalog. The listed range runs from 10 mg film-coated tablets · 56 tablets at €2,999.30 to 10 mg film-coated tablets · 182 tablets at €7,223.03. 4 package references also include recorded U.S. cash-price context ($6,759.52 – $13,519.05); compare only like-for-like strength, form and quantity. Figures are informational, not a quote or supply guarantee.
Estimated medicine cost range€2,999.30 – €7,223.03
Source-supported U.S. cash context$6,759.52 – $13,519.05
Estimated price differenceup to €7,793.94
Last recorded source review
Reference profile
Clear information.
Case-specific review.
The listed range runs from 10 mg film-coated tablets · 56 tablets at €2,999.30 to 10 mg film-coated tablets · 182 tablets at €7,223.03. These figures are catalog references, not an offer to sell or a guarantee of supply. The correct product, package, destination, licensed provider and importer must be reviewed for each request.
Package-level price scope
The listed range runs from 10 mg film-coated tablets · 56 tablets at €2,999.30 to 10 mg film-coated tablets · 182 tablets at €7,223.03. Strength, dosage form and quantity can materially change a like-for-like comparison.
Comparison evidence
4 package references also include recorded U.S. cash-price context ($6,759.52 – $13,519.05); compare only like-for-like strength, form and quantity.
Package references
XELJANZ listed formats
European figures are dated estimated medicine cost references. U.S. cash context appears only where the catalog retains source provenance; compare the exact strength, form and quantity.
14 of 14 package references shown
No package references match that search. Try a shorter strength, dosage form, supplier or PZN.
| Package reference | Estimated medicine cost reference | Comparable U.S. cash reference | Estimated difference | Source notes | Select |
|---|---|---|---|---|---|
| 10 mg film-coated tablets · 56 tablets Pfizer Pharma GmbH · PZN 14155692 | €2,999.30 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 10 mg film-coated tablets · 56 tablets PARANOVA PACK A/S · PZN 15231981 | €3,086.80 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 10 mg film-coated tablets · 56 tablets kohlpharma GmbH · PZN 15193714 | €3,122.34 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 11 mg prolonged-release tablets · 91 tablets Pfizer Pharma GmbH · PZN 14275290 | €4,033.66 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 5 mg film-coated tablets · 182 tablets Pfizer Pharma GmbH · PZN 13577882 | €4,033.66 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 11 mg prolonged-release tablets · 91 tablets Pfizer Pharma GmbH | €4,033.67 | $6,759.52 | €1,880.13 | Imported legacy U.S. cash comparison; source package figure $4457.09; external source URL not recorded in the source workbook | Request this package |
| 5 mg film-coated tablets · 182 tablets Pfizer Pharma GmbH | €4,033.67 | $13,519.05 | €7,793.94 | Imported legacy U.S. cash comparison; source package figure $4457.09; external source URL not recorded in the source workbook | Request this package |
| 5 mg film-coated tablets · 182 tablets axicorp Pharma B.V. · PZN 14244579 | €4,217.49 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 5 mg film-coated tablets · 182 tablets PARANOVA PACK A/S · PZN 17524115 | €4,217.81 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 11 mg prolonged-release tablets · 91 tablets Abacus Medicine A/S · PZN 16687849 | €4,224.69 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 11 mg prolonged-release tablets · 91 tablets kohlpharma GmbH · PZN 16941992 | €4,224.69 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 5 mg film-coated tablets · 182 tablets kohlpharma GmbH · PZN 14401613 | €4,224.78 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 10 mg film-coated tablets · 112 tablets Pfizer Pharma GmbH · PZN 14155700 | €4,854.29 | $8,319.41 | €2,424.24 | Imported legacy U.S. cash comparison; source package figure $4457.09; external source URL not recorded in the source workbook Recorded review: | Request this package |
| 10 mg film-coated tablets · 182 tablets Pfizer Pharma GmbH · PZN 14155717 | €7,223.03 | $13,519.05 | €4,604.58 | Imported legacy U.S. cash comparison; source package figure $4457.09; external source URL not recorded in the source workbook Recorded review: | Request this package |
Data scopeReference information, not a quote
Displayed amounts are dated catalog references and may not include every tax, dispensing, shipping or route-specific cost. Exact identity, availability, prescription, destination and import route require separate review. U.S. amounts are shown only for records with retained comparison provenance. US Med Access does not dispense or sell medicines and provides no medical advice. Review the pricing and data methodology before comparing packages.
How the references are preparedSources and editorial responsibility
Where this XELJANZ reference comes from
US Med Access publishes this page as an independent reference-information provider. Package records are retained with their available source notes and review dates; missing provenance is stated rather than inferred.
- Publisher and author
- US Med Access editorial team
- Recorded source review
- Reference scope
- 14 active European package records with supported U.S. cash-price context where listed
01
European package source recordEuropean reference · medipreis.de
↗
02
European package source recordEuropean reference · medipreis.de
↗
03
European package source recordEuropean reference · medipreis.de
↗
04
European package source recordEuropean reference · medipreis.de
↗
05
European package source recordEuropean reference · medipreis.de
↗
06
European package source recordEuropean reference · medipreis.de
↗
07
European package source recordEuropean reference · medipreis.de
↗
08
Drugs.com medicine price guideU.S. cash-price context · drugs.com
↗
09
US Med Access pricing and data methodologyMethodology · usmedaccess.com
↗
Frequently asked questions
XELJANZ price and package questions
Direct answers based on the package records shown on this page. They do not replace medical, regulatory or dispensing advice.
01What is the listed XELJANZ price in Europe?
The 14 listed European package references range from €2,999.30 – €7,223.03. The exact amount depends on strength, dosage form and pack quantity, so compare the specific package row rather than the range alone.
02How does the XELJANZ European reference compare with U.S. cash prices?
Recorded U.S. cash-price context is $6,759.52 – $13,519.05 across 4 supported package references. A comparison is meaningful only where strength, form and quantity are equivalent; source notes identify normalization or limitations.
03Are the listed XELJANZ amounts a quote or sale offer?
No. They are informational catalog references. US Med Access is an independent sourcing consultant and does not sell or dispense medicines. Current availability, route, prescription and total cost require separate review.
04How do I request the correct XELJANZ package?
Select the row that matches the prescribed strength, dosage form and quantity, then include the destination and request details. A package-level review is required before any next step.
Availability and logistics
Need a package-level review?
Start with the medication, package and destination. The sourcing team will assess the specific request without promising a supply, import or delivery outcome.